FMR discloses 5.4% Harmony Biosciences (HRMY) ownership stake

Rhea-AI Filing Summary

FMR LLC has filed an amended Schedule 13G reporting beneficial ownership of 3,112,812.16 shares of Harmony Biosciences Holdings, Inc. common stock, representing 5.4% of the class as of the reporting date.

FMR LLC reports sole voting power over 3,109,042 shares and sole dispositive power over 3,112,812.16 shares, with no shared voting or dispositive power. Abigail P. Johnson is also listed as a reporting person with sole dispositive power over 3,112,812.16 shares and no voting power. The filers certify the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Harmony Biosciences.

Insights

Equity ownership and disclosure analyst

FMR reports a passive 5.4% stake in Harmony Biosciences, crossing the key disclosure threshold.

The filing shows FMR LLC and Abigail P. Johnson beneficially owning 3,112,812.16 Harmony Biosciences common shares, or 5.4% of the class. FMR has sole voting power over 3,109,042 shares and sole dispositive power over 3,112,812.16 shares, with no shared powers indicated.

The certification states the position is held in the ordinary course of business and not to change or influence control of Harmony Biosciences. This language characterizes the stake as passive under the Schedule 13G framework. Future ownership changes, if any, would typically appear in subsequent beneficial ownership reports.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 7)

HARMONY BIOSCIENCES HOLDINGS INC

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

413197104

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 413197104

1

Names of Reporting Persons

FMR LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,109,042.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,112,812.16
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,112,812.16

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.4 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP No. 413197104

1

Names of Reporting Persons

Abigail P. Johnson

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,112,812.16
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,112,812.16

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.4 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: HARMONY BIOSCIENCES HOLDINGS INC
(b)	Address of issuer's principal executive offices: 630 W Germantown Pike,Suite 215,Plymouth Meeting,PA,USA,19462
Item 2.
(a)	Name of person filing: FMR LLC
(b)	Address or principal business office or, if none, residence: 245 Summer Street, Boston, Massachusetts 02210
(c)	Citizenship: Not applicable
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP No.: 413197104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 3112812.16
(b)	Percent of class: 5.4 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page.
	(ii) Shared power to vote or to direct the vote: 0.00
	(iii) Sole power to dispose or to direct the disposition of: 3112812.16
	(iv) Shared power to dispose or to direct the disposition of: 0.00
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of HARMONY BIOSCIENCES HOLDINGS INC. No one other person's interest in the COMMON STOCK of HARMONY BIOSCIENCES HOLDINGS INC is more than five percent of the total outstanding COMMON STOCK.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See attached Exhibit 99.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

FMR LLC

Signature:	Stephanie J. Brown
Name/Title:	Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:	02/04/2026

Abigail P. Johnson

Signature:	Stephanie J. Brown
Name/Title:	Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**
Date:	02/04/2026

Comments accompanying signature: * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.

Exhibit Information

Please see Exhibit 99 for 13d-1(k) (1) agreement.

FAQ

What ownership stake in Harmony Biosciences (HRMY) does FMR LLC report?

FMR LLC reports beneficial ownership of 3,112,812.16 shares of Harmony Biosciences common stock, representing 5.4% of the outstanding class. This crosses the 5% disclosure threshold that requires Schedule 13G/A reporting for significant shareholders.

Who are the reporting persons in this Harmony Biosciences (HRMY) Schedule 13G/A?

The Schedule 13G/A lists FMR LLC and Abigail P. Johnson as reporting persons. FMR LLC is organized in Delaware, while Abigail P. Johnson is a United States citizen, each reporting beneficial ownership interests in Harmony Biosciences common stock.

How much voting and dispositive power does FMR LLC have over HRMY shares?

FMR LLC reports sole voting power over 3,109,042 Harmony Biosciences shares and sole dispositive power over 3,112,812.16 shares. It reports no shared voting or shared dispositive power, indicating exclusive authority over these positions.

How much ownership does Abigail P. Johnson report in Harmony Biosciences (HRMY)?

Abigail P. Johnson reports beneficial ownership of 3,112,812.16 Harmony Biosciences common shares, representing 5.4% of the class. She has sole dispositive power over these shares, with no sole or shared voting power described in the filing.

Is FMR LLC’s Harmony Biosciences (HRMY) stake described as passive or control-seeking?

The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of Harmony Biosciences, indicating a passive investment posture under the Schedule 13G framework.

Do other investors share in the economic interest of FMR LLC’s HRMY holdings?

The filing notes that one or more other persons may have rights to receive dividends or sale proceeds from Harmony Biosciences shares. However, it states that no single such person has an interest in more than 5% of the total outstanding common stock.